Colruyt Group financials
Colruyt Group
Country: BE Reporting currency: EUR Latest annual report: 2026-03-31
LEI:
5493000O0NZ1BCXO8K39 Financial statements
(EUR, as reported — unscaled; 115 line items across 2 annual periods)
| Line item | 2026 | 2025 |
|---|---|---|
| Income statement | ||
| Revenue | €10.57B | €10.25B |
| Cost of sales | €7.35B | €7.13B |
| Gross profit | €3.22B | €3.12B |
| Other income | €192.7M | €162.2M |
| Employee benefits expense | €1.75B | €1.68B |
| Operating profit (EBIT) | €464.9M | €469.2M |
| Net finance income / (cost) | -€19.4M | €800.0K |
| Finance costs | €33.5M | €36.3M |
| Profit before tax | €440.8M | €470.2M |
| Income tax expense | €104.1M | €118.5M |
| Profit for the year | €303.7M | €337.0M |
| — attributable to owners | €303.5M | €337.3M |
| — attributable to NCI | €200.0K | -€300.0K |
| Total comprehensive income | €305.0M | €347.4M |
| Per share | ||
| Basic EPS | €2.53 | €2.73 |
| Diluted EPS | €2.53 | €2.73 |
| Free cash flow / share | €2.27 | €2.11 |
| Cash flow statement | ||
| Net cash from operating activities | €744.7M | €738.6M |
| Net cash from investing activities | -€360.9M | -€357.0M |
| Net cash from financing activities | -€424.0M | -€530.4M |
| Dividends paid | €165.6M | €171.1M |
| Proceeds from borrowings | €18.2M | €25.5M |
| Repayments of borrowings | €123.4M | €139.3M |
| Lease liability payments | €86.3M | €76.4M |
| Balance sheet | ||
| Total assets | €6.49B | €6.46B |
| Non-current assets | €4.39B | €4.35B |
| Intangible assets & goodwill | €557.9M | €449.2M |
| Current assets | €2.10B | €2.12B |
| Inventories | €731.8M | €776.0M |
| Trade & other receivables | €542.6M | €539.8M |
| Cash & equivalents | €586.2M | €626.8M |
| Total equity | €3.26B | €3.17B |
| — attributable to owners | €3.26B | €3.17B |
| Non-controlling interests | €200.0K | -€400.0K |
| Non-current liabilities | €816.2M | €933.8M |
| Current liabilities | €2.41B | €2.36B |
| Deferred tax liabilities | €81.5M | €96.3M |
| Derived metrics | ||
| Free cash flow | €272.7M | €259.9M |
| Operating margin | 4.4% | 4.6% |
| Net margin | 2.9% | 3.3% |
| Return on equity | 9.3% | 10.6% |
| Cash conversion ratio | 2.45× | 2.19× |
| Capex coverage | 1.58× | 1.54× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | €36.7M | -€18.3M |
| Adjustments For Decrease Increase In Trade and Other Receivables | €15.8M | €55.1M |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €481.5M | €412.1M |
| Adjustments For Finance Income Cost | -€19.6M | €500.0K |
| Adjustments For Increase Decrease In Trade and Other Payables | -€15.2M | -€27.2M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -€83.2M | -€7.2M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | -€4.7M | €200.0K |
| Basic Earnings Loss Per Share From Continuing Operations | €2.80 | €2.85 |
| Basic Earnings Loss Per Share From Discontinued Operations | €-0.28 | €-0.12 |
| Cancellation of Treasury Shares | €0 | €0 |
| Cash Advances and Loans Made To Other Parties Classified As Investing Activities | €11.0M | €3.4M |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €586.3M | €626.7M |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €231.1M | €5.9M |
| Cash Flows From Used In Operations Before Changes In Working Capital | €768.9M | €848.1M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €68.3M | €47.7M |
| Comprehensive Income Attributable To Noncontrolling Interests | €200.0K | -€300.0K |
| Comprehensive Income Attributable To Owners of Parent | €304.8M | €347.7M |
| Current Financial Assets | €107.7M | €65.3M |
| Current Provisions | €61.2M | €700.0K |
| Current Tax Assets Current | €20.4M | €16.5M |
| Current Tax Liabilities Current | €19.3M | €29.8M |
| Deferred Tax Assets | €54.7M | €13.0M |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €414.2M | €385.5M |
| Diluted Earnings Loss Per Share From Continuing Operations | €2.80 | €2.85 |
| Diluted Earnings Loss Per Share From Discontinued Operations | €-0.28 | €-0.12 |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners | €164.4M | — |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | €1.38 | — |
| Dividends Received Classified As Operating Activities | €300.0K | €1.0M |
| Dividends Recognised As Distributions To Owners Per Share | €1.38 | — |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€400.0K | €0 |
| Equity and Liabilities | €6.49B | €6.46B |
| Finance Income | €14.1M | €37.1M |
| Income Taxes Paid Refund Classified As Operating Activities | €119.8M | €116.3M |
| Increase Decrease In Cash and Cash Equivalents | -€40.1M | -€148.8M |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | €200.0K | — |
| Increase Decrease Through Transactions With Owners | -€216.0M | -€349.0M |
| Increase Decrease Through Transfers and Other Changes Equity | €6.7M | €100.0K |
| Intangible Assets Other Than Goodwill | €417.1M | €423.0M |
| Interest Paid Classified As Financing Activities | €20.6M | €21.6M |
| Investment Accounted For Using Equity Method | €278.0M | €269.0M |
| Issue of Equity | €3.2M | €6.5M |
| Issued Capital | €387.6M | €384.7M |
| Liabilities | €3.23B | €3.29B |
| Liabilities Included In Disposal Groups Classified As Held For Sale | €5.2M | €0 |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €28.5M | €0 |
| Noncurrent Financial Assets | €21.0M | €27.3M |
| Noncurrent Provisions | €10.7M | €10.2M |
| Noncurrent Recognised Liabilities Defined Benefit Plan | €64.5M | €71.7M |
| Other Adjustments To Reconcile Profit Loss | €400.0K | -€4.0M |
| Other Comprehensive Income | €1.3M | €10.4M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -€2.4M | -€500.0K |
| Other Comprehensive Income Net of Tax Financial Assets Measured At Fair Value Through Other Comprehensive Income | €10.3M | -€1.9M |
| Other Comprehensive Income Net of Tax Gains Losses From Investments In Equity Instruments | -€7.7M | €200.0K |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €400.0K | €12.6M |
| Other Expense By Nature | €31.1M | €31.5M |
| Other Noncurrent Receivables | €47.7M | €43.0M |
| Payments To Acquire Or Redeem Entitys Shares | €60.7M | €176.0M |
| Proceeds From Disposals of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | €36.0M | €14.7M |
| Proceeds From Issue of Ordinary Shares | €2.9M | €5.7M |
| Proceeds From Sales of Investments Accounted For Using Equity Method | €0 | €300.0K |
| Proceeds From Sales Or Maturity of Financial Instruments Classified As Investing Activities | €44.2M | €185.0M |
| Profit Loss From Continuing Operations | €336.7M | €351.7M |
| Profit Loss From Discontinued Operations | -€33.0M | -€14.8M |
| Property Plant and Equipment Including Rightofuse Assets | €3.01B | €3.12B |
| Purchase of Financial Instruments Classified As Investing Activities | €64.1M | €17.5M |
| Purchase of Interests In Investments Accounted For Using Equity Method | €56.9M | €15.7M |
| Purchase of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | €472.0M | €478.7M |
| Purchase of Treasury Shares | €60.7M | €175.2M |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Be Reclassified To Profit Or Loss Net of Tax | €500.0K | -€100.0K |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Not Be Reclassified To Profit Or Loss Net of Tax | €200.0K | €0 |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | -€4.7M | €200.0K |
| Trade and Other Current Payables To Trade Suppliers | €1.37B | €1.39B |
Methodology
Every line item above is a fact tagged in Colruyt Group's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.